M.P.J. van Goor

542 total citations
7 papers, 362 citations indexed

About

M.P.J. van Goor is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, M.P.J. van Goor has authored 7 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Epidemiology. Recurrent topics in M.P.J. van Goor's work include Acute Ischemic Stroke Management (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Moyamoya disease diagnosis and treatment (1 paper). M.P.J. van Goor is often cited by papers focused on Acute Ischemic Stroke Management (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Moyamoya disease diagnosis and treatment (1 paper). M.P.J. van Goor collaborates with scholars based in Netherlands. M.P.J. van Goor's co-authors include Diederik W.J. Dippel, Frank W.G. Leebeek, E. Gómez, T.N. Bongers, Moniek P.M. de Maat, Huub H.D.M. van Vliet, Peter J. Koudstaal, M.P.M. De Maat, Ana H.C. Guimarães and D.C. Rijken and has published in prestigious journals such as Stroke, Journal of Neurology Neurosurgery & Psychiatry and Journal of Thrombosis and Haemostasis.

In The Last Decade

M.P.J. van Goor

7 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.P.J. van Goor Netherlands 7 216 79 75 68 68 7 362
Giuliana Merati Italy 9 263 1.2× 69 0.9× 99 1.3× 44 0.6× 56 0.8× 14 422
Sayaka Moriguchi‐Goto Japan 14 121 0.6× 76 1.0× 105 1.4× 90 1.3× 65 1.0× 24 410
Michelle Sonneveld Netherlands 11 213 1.0× 188 2.4× 120 1.6× 61 0.9× 61 0.9× 15 463
Megha Bajaj United States 8 316 1.5× 45 0.6× 68 0.9× 85 1.3× 72 1.1× 14 484
Tine Wyseure United States 8 206 1.0× 20 0.3× 33 0.4× 54 0.8× 61 0.9× 15 350
Howard H.W. Chan Canada 10 156 0.7× 26 0.3× 67 0.9× 50 0.7× 34 0.5× 31 319
M. Borrell Spain 11 199 0.9× 15 0.2× 79 1.1× 77 1.1× 78 1.1× 32 360
P. Arcieri Italy 13 455 2.1× 38 0.5× 41 0.5× 256 3.8× 40 0.6× 16 667
Eugene H. C. Liu Singapore 5 205 0.9× 17 0.2× 150 2.0× 55 0.8× 31 0.5× 6 355
Astrid Dossenbach‐Glaninger Austria 9 148 0.7× 37 0.5× 51 0.7× 29 0.4× 16 0.2× 16 317

Countries citing papers authored by M.P.J. van Goor

Since Specialization
Citations

This map shows the geographic impact of M.P.J. van Goor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.P.J. van Goor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.P.J. van Goor more than expected).

Fields of papers citing papers by M.P.J. van Goor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.P.J. van Goor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.P.J. van Goor. The network helps show where M.P.J. van Goor may publish in the future.

Co-authorship network of co-authors of M.P.J. van Goor

This figure shows the co-authorship network connecting the top 25 collaborators of M.P.J. van Goor. A scholar is included among the top collaborators of M.P.J. van Goor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.P.J. van Goor. M.P.J. van Goor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Goor, M.P.J. van, et al.. (2008). Low protein Z levels but not the protein Z gene G79A polymorphism are a risk factor for ischemic stroke. Thrombosis Research. 123(2). 213–218. 21 indexed citations
2.
Bongers, T.N., Moniek P.M. de Maat, M.P.J. van Goor, et al.. (2006). High von Willebrand Factor Levels Increase the Risk of First Ischemic Stroke. Stroke. 37(11). 2672–2677. 189 indexed citations
3.
Leebeek, Frank W.G., M.P.J. van Goor, Ana H.C. Guimarães, et al.. (2005). High functional levels of thrombin-activatable fibrinolysis inhibitor are associated with an increased risk of first ischemic stroke. Journal of Thrombosis and Haemostasis. 3(10). 2211–2218. 85 indexed citations
4.
Bos, Michiel J., M.P.J. van Goor, Peter J. Koudstaal, & Diederik W.J. Dippel. (2005). Plasma homocysteine is a risk factor for recurrent vascular events in young patients with an ischaemic stroke or TIA. Journal of Neurology. 252(3). 332–337. 20 indexed citations
5.
Goor, M.P.J. van. (2004). The - 148 C/T fibrinogen gene polymorphism and fibrinogen levels in ischaemic stroke: a case-control study. Journal of Neurology Neurosurgery & Psychiatry. 76(1). 121–123. 14 indexed citations
6.
Goor, M.P.J. van, et al.. (2004). Do antiphospholipid antibodies increase the long-term risk of thrombotic complications in young patients with a recent TIA or ischemic stroke?. Acta Neurologica Scandinavica. 109(6). 410–415. 22 indexed citations
7.
Gómez, E., et al.. (2002). Elevated prothrombin is a risk factor for cerebral arterial ischemia in young adults. Clinical Neurology and Neurosurgery. 104(4). 285–288. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026